Advertisement

Index by author

September 01, 2014; Volume 350,Issue 3

A

  1. Akazawa, Hitomi

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  2. Al-Azayzih, Ahmad

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  3. Alhusban, Ahmed

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  4. Amada, Naoki

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  5. Ansonoff, Michael

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  6. Arnt, Jørn

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  7. Aronsen, Jan Magnus

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

B

  1. Bate, Simon T.

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  2. Becq, Frédéric

    1. Searching for Combinations of Small-Molecule Correctors to Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
      Clément Boinot, Mathilde Jollivet Souchet, Romain Ferru-Clément and Frédéric Becq
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 624-634; DOI: https://doi.org/10.1124/jpet.114.214890

  3. Benny, Ofra

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  4. Boinot, Clément

    1. Searching for Combinations of Small-Molecule Correctors to Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
      Clément Boinot, Mathilde Jollivet Souchet, Romain Ferru-Clément and Frédéric Becq
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 624-634; DOI: https://doi.org/10.1124/jpet.114.214890

  5. Boléa, Christelle

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  6. Bonev, Adrian D.

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  7. Brown, Karen

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

  8. Brown, William D.

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  9. Browne, Susan E.

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  10. Bundgaard, Christoffer

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  11. Burdick, Jason A.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  12. Busse, Eric

    1. Gambierol Inhibition of Voltage-Gated Potassium Channels Augments Spontaneous Ca2+ Oscillations in Cerebrocortical Neurons
      Zhengyu Cao, Yanjun Cui, Eric Busse, Suneet Mehrotra, Jon D. Rainier and Thomas F. Murray
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 615-623; DOI: https://doi.org/10.1124/jpet.114.215319

C

  1. Campbell, Carly A.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  2. Campo, Brice

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  3. Cao, Zhengyu

    1. Gambierol Inhibition of Voltage-Gated Potassium Channels Augments Spontaneous Ca2+ Oscillations in Cerebrocortical Neurons
      Zhengyu Cao, Yanjun Cui, Eric Busse, Suneet Mehrotra, Jon D. Rainier and Thomas F. Murray
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 615-623; DOI: https://doi.org/10.1124/jpet.114.215319

  4. Celanire, Sylvain

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  5. Chan, S. W.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  6. Chiba, Masato

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  7. Chojnacka, Kinga

    1. The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor
      Roger L. Papke, Kinga Chojnacka and Nicole A. Horenstein
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 665-680; DOI: https://doi.org/10.1124/jpet.114.215236

  8. Christophersen, Palle

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  9. Cohen, Gadi

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  10. Copeland, Robert A.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  11. Cui, Yanjun

    1. Gambierol Inhibition of Voltage-Gated Potassium Channels Augments Spontaneous Ca2+ Oscillations in Cerebrocortical Neurons
      Zhengyu Cao, Yanjun Cui, Eric Busse, Suneet Mehrotra, Jon D. Rainier and Thomas F. Murray
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 615-623; DOI: https://doi.org/10.1124/jpet.114.215319

D

  1. Daigle, Scott R.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  2. Davis, Matthew J.

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  3. Duvoisin, Robert

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  4. Dyhring, Tino

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

E

  1. Eble, Johannes A.

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  2. Echols, Randall L.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

F

  1. Fagan, Susan C.

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  2. Ferru-Clément, Romain

    1. Searching for Combinations of Small-Molecule Correctors to Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
      Clément Boinot, Mathilde Jollivet Souchet, Romain Ferru-Clément and Frédéric Becq
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 624-634; DOI: https://doi.org/10.1124/jpet.114.214890

  3. Fischer, W.

    1. Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
      M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569

  4. Fonsi, Massimiliano

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  5. Freels, Parker D.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  6. Fujimura, Morihiro

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  7. Futamura, Takashi

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

G

  1. Gao, Fei

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  2. Girard, Françoise

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  3. Goc, Anna

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  4. Gorman, Joseph H.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  5. Gorman, Robert C.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  6. Grinnell, Steven G.

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  7. Grunnet, Morten

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  8. Gu, Leyi

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

H

  1. Hansen, Carl Frederik

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  2. Hansen, Gitte

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  3. Hansen, Henrik H.

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  4. Hashimoto, Tadatoshi

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  5. Hausman, Marvin

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  6. Hentzer, Morten

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  7. Hirakata, Mikito

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  8. Hoi, Maggie P. M.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  9. Horenstein, Nicole A.

    1. The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor
      Roger L. Papke, Kinga Chojnacka and Nicole A. Horenstein
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 665-680; DOI: https://doi.org/10.1124/jpet.114.215236

  10. Hougaard, Charlotte

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  11. Howells, Lynne M.

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

I

  1. Ishii, Yasuyuki

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  2. Ito, Nobuaki

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  3. Iwanowicz, Dorothy

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  4. Izumimoto, Naoki

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

J

  1. Jackson, Edwin K.

    1. The Guanosine-Adenosine Interaction Exists In Vivo
      Edwin K. Jackson and Zaichuan Mi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 719-726; DOI: https://doi.org/10.1124/jpet.114.216978

  2. Jelsing, Jacob

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  3. Johnston, Danielle

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  4. Jollivet Souchet, Mathilde

    1. Searching for Combinations of Small-Molecule Correctors to Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
      Clément Boinot, Mathilde Jollivet Souchet, Romain Ferru-Clément and Frédéric Becq
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 624-634; DOI: https://doi.org/10.1124/jpet.114.214890

  5. Jørgensen, Susanne

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

K

  1. Kaiser, M.

    1. Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
      M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569

  2. Kalinichev, Mikhail

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  3. Kang, Jihee Lee

    1. RhoA/Phosphatidylinositol 3-Kinase/Protein Kinase B/Mitogen-Activated Protein Kinase Signaling after Growth Arrest–Specific Protein 6/Mer Receptor Tyrosine Kinase Engagement Promotes Epithelial Cell Growth and Wound Repair via Upregulation of Hepatocyte Growth Factor in Macrophages
      Ye-Ji Lee, Hyun-Jung Park, So-Youn Woo, Eun-Mi Park and Jihee Lee Kang
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 563-577; DOI: https://doi.org/10.1124/jpet.114.215673

  4. Kanie, Sayoko

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  5. Katzehendler, Jehoshua

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  6. Kawai, Koji

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  7. Kikuchi, Tetsuro

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  8. Klaus, Christine R.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  9. Klein, Thomas

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  10. Kobayashi, Ryosuke

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  11. Komagata, Toshikazu

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  12. Korsgaard, Mads P. G.

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  13. Kwan, Y. W.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

L

  1. Lahiani, Adi

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  2. Lazarovici, Philip

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  3. Lee, Simon M. Y.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  4. Lee, Ye-Ji

    1. RhoA/Phosphatidylinositol 3-Kinase/Protein Kinase B/Mitogen-Activated Protein Kinase Signaling after Growth Arrest–Specific Protein 6/Mer Receptor Tyrosine Kinase Engagement Promotes Epithelial Cell Growth and Wound Repair via Upregulation of Hepatocyte Growth Factor in Macrophages
      Ye-Ji Lee, Hyun-Jung Park, So-Youn Woo, Eun-Mi Park and Jihee Lee Kang
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 563-577; DOI: https://doi.org/10.1124/jpet.114.215673

  5. Le Poul, Emmanuel

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  6. Lerdrup, Linda

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819

  7. Le Rouzic, Valerie

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  8. Leung, George P. H.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  9. Levy, Finn Olav

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  10. Li, Rachel W. S.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  11. Lothe, Gustav B.

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

M

  1. Maeda, Kenji

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  2. Mahale, Jagdish

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

  3. Majumdar, Susruta

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  4. Marcinkiewicz, Cezary

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  5. Mark, Michael

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  6. Mayoux, Eric

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

  7. McGarvey, Jeremy R.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  8. McQuade, Robert D.

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  9. McVeigh, Laura

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

  10. Mehrotra, Suneet

    1. Gambierol Inhibition of Voltage-Gated Potassium Channels Augments Spontaneous Ca2+ Oscillations in Cerebrocortical Neurons
      Zhengyu Cao, Yanjun Cui, Eric Busse, Suneet Mehrotra, Jon D. Rainier and Thomas F. Murray
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 615-623; DOI: https://doi.org/10.1124/jpet.114.215319

  11. Meier, Silja

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  12. Mi, Zaichuan

    1. The Guanosine-Adenosine Interaction Exists In Vivo
      Edwin K. Jackson and Zaichuan Mi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 719-726; DOI: https://doi.org/10.1124/jpet.114.216978

  13. Michel, Martin C.

    1. Hope for Disease-Modifying Treatment of Systemic Sclerosis/Scleroderma
      Martin C. Michel
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 480-482; DOI: https://doi.org/10.1124/jpet.114.213520comm

  14. Moltzau, Lise Román

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  15. Momen, Shinobu

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  16. Momic, Tatjana

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  17. Mørk, Arne

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  18. Mou, Shan

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  19. Moyer, Mikel P.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  20. Murray, Thomas F.

    1. Gambierol Inhibition of Voltage-Gated Potassium Channels Augments Spontaneous Ca2+ Oscillations in Cerebrocortical Neurons
      Zhengyu Cao, Yanjun Cui, Eric Busse, Suneet Mehrotra, Jon D. Rainier and Thomas F. Murray
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 615-623; DOI: https://doi.org/10.1124/jpet.114.215319

N

  1. Narayan, Ankita

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  2. Nardi, Antonio

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  3. Nausch, Bernhard

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  4. Nelson, Mark T.

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  5. Ni, Zhaohui

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  6. Nielsen, Vibeke

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  7. Nörenberg, W.

    1. Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
      M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569

  8. Novack, Craig P.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  9. Noy, Efrat

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

O

  1. Ohe, Tomoyuki

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  2. Ohtsuki, Sumio

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  3. Okanishi, Satoshi

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  4. Olesen, Søren-Peter

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  5. Olhava, Edward J.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  6. Ørstavik, Øivind

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  7. Osnes, Jan-Bjørn

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

P

  1. Papke, Roger L.

    1. The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor
      Roger L. Papke, Kinga Chojnacka and Nicole A. Horenstein
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 665-680; DOI: https://doi.org/10.1124/jpet.114.215236

  2. Park, Eun-Mi

    1. RhoA/Phosphatidylinositol 3-Kinase/Protein Kinase B/Mitogen-Activated Protein Kinase Signaling after Growth Arrest–Specific Protein 6/Mer Receptor Tyrosine Kinase Engagement Promotes Epithelial Cell Growth and Wound Repair via Upregulation of Hepatocyte Growth Factor in Macrophages
      Ye-Ji Lee, Hyun-Jung Park, So-Youn Woo, Eun-Mi Park and Jihee Lee Kang
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 563-577; DOI: https://doi.org/10.1124/jpet.114.215673

  3. Park, Hyun-Jung

    1. RhoA/Phosphatidylinositol 3-Kinase/Protein Kinase B/Mitogen-Activated Protein Kinase Signaling after Growth Arrest–Specific Protein 6/Mer Receptor Tyrosine Kinase Engagement Promotes Epithelial Cell Growth and Wound Repair via Upregulation of Hepatocyte Growth Factor in Macrophages
      Ye-Ji Lee, Hyun-Jung Park, So-Youn Woo, Eun-Mi Park and Jihee Lee Kang
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 563-577; DOI: https://doi.org/10.1124/jpet.114.215673

  4. Pasternak, Gavril W.

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  5. Pehrson, Alan L.

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  6. Pettaway, Sara

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  7. Pintar, John E.

    1. Pharmacologic Characterization in the Rat of a Potent Analgesic Lacking Respiratory Depression, IBNtxA
      Steven G. Grinnell, Susruta Majumdar, Ankita Narayan, Valerie Le Rouzic, Michael Ansonoff, John E. Pintar and Gavril W. Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 710-718; DOI: https://doi.org/10.1124/jpet.114.213199

  8. Poli, Sonia

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  9. Pollock, Roy M.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

Q

  1. Qvigstad, Eirik

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

R

  1. Raber, Jacob

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  2. Raimondi, Alejandra

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  3. Rainier, Jon D.

    1. Gambierol Inhibition of Voltage-Gated Potassium Channels Augments Spontaneous Ca2+ Oscillations in Cerebrocortical Neurons
      Zhengyu Cao, Yanjun Cui, Eric Busse, Suneet Mehrotra, Jon D. Rainier and Thomas F. Murray
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 615-623; DOI: https://doi.org/10.1124/jpet.114.215319

  4. Reynolds, Ian J.

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

  5. Rode, Frederik

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  6. Rønn, Lars C. B.

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  7. Royer-Urios, Isabelle

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

S

  1. Sale, Stewart

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

  2. Schaefer, M.

    1. Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
      M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569

  3. Scott, Margaret Porter

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  4. Senderowitz, Hanoch

    1. Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity
      Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643

  5. Shao, Xinghua

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  6. Shimada, Jun

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  7. Shuman, James A.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  8. Sit, Albert S. M.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  9. Sjaastad, Ivar

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  10. Skogestad, Jonas

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  11. Skomedal, Tor

    1. Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat Ventricle
      Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B. Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy and Eirik Qvigstad
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 681-690; DOI: https://doi.org/10.1124/jpet.114.214882

  12. Smith, Jesse J.

    1. DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
      Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577

  13. Sobottka, H.

    1. Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
      M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569

  14. Somanath, Payaningal R.

    1. Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
      Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382

  15. Spinale, Francis G.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  16. Stensbøl, Tine Bryan

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  17. Steward, William P.

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

  18. Strøbæk, Dorte

    1. NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
      Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662

  19. Sugino, Haruhiko

    1. Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Robert D. McQuade, Tine Bryan Stensbøl, Christoffer Bundgaard, Jørn Arnt and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 605-614; DOI: https://doi.org/10.1124/jpet.114.213819
    2. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

T

  1. Terasaki, Tetsuya

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  2. Thomas, Anne

    1. Translating Curcumin to the Clinic for Lung Cancer Prevention: Evaluation of the Preclinical Evidence for Its Utility in Primary, Secondary, and Tertiary Prevention Strategies
      Lynne M. Howells, Jagdish Mahale, Stewart Sale, Laura McVeigh, William P. Steward, Anne Thomas and Karen Brown
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 483-494; DOI: https://doi.org/10.1124/jpet.114.216333

  3. Tian, Lei

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

U

  1. Uchida, Yasuo

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  2. Uslaner, Jason M.

    1. Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
      Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437

V

  1. Vanhoutte, Paul M.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  2. Vrang, Niels

    1. The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
      Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454

W

  1. Wakayama, Kentaro

    1. Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
      Yasuo Uchida, Kentaro Wakayama, Sumio Ohtsuki, Masato Chiba, Tomoyuki Ohe, Yasuyuki Ishii and Tetsuya Terasaki
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 578-588; DOI: https://doi.org/10.1124/jpet.114.214536

  2. Wang, Ling

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  3. Wang, Qin

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  4. Woo, So-Youn

    1. RhoA/Phosphatidylinositol 3-Kinase/Protein Kinase B/Mitogen-Activated Protein Kinase Signaling after Growth Arrest–Specific Protein 6/Mer Receptor Tyrosine Kinase Engagement Promotes Epithelial Cell Growth and Wound Repair via Upregulation of Hepatocyte Growth Factor in Macrophages
      Ye-Ji Lee, Hyun-Jung Park, So-Youn Woo, Eun-Mi Park and Jihee Lee Kang
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 563-577; DOI: https://doi.org/10.1124/jpet.114.215673

  5. Wu, Bei

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

X

  1. Xu, Weijia

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  2. Xu, Xiaoping

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

Y

  1. Yamashita, Hiroshi

    1. Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
      Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Naoki Amada, Jun Shimada, Takashi Futamura, Hiroshi Yamashita, Nobuaki Ito, Robert D. McQuade, Arne Mørk, Alan L. Pehrson, Morten Hentzer, Vibeke Nielsen, Christoffer Bundgaard, Jørn Arnt, Tine Bryan Stensbøl and Tetsuro Kikuchi
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 589-604; DOI: https://doi.org/10.1124/jpet.114.213793

  2. Yang, C.

    1. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells
      Rachel W. S. Li, C. Yang, Albert S. M. Sit, Y. W. Kwan, Simon M. Y. Lee, Maggie P. M. Hoi, S. W. Chan, Marvin Hausman, Paul M. Vanhoutte and George P. H. Leung
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 691-700; DOI: https://doi.org/10.1124/jpet.114.214049

  3. Yao, Jufang

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205

  4. Yoshikawa, Satoru

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

  5. Yoshimura, Naoki

    1. Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder
      Morihiro Fujimura, Naoki Izumimoto, Shinobu Momen, Satoru Yoshikawa, Ryosuke Kobayashi, Sayoko Kanie, Mikito Hirakata, Toshikazu Komagata, Satoshi Okanishi, Tadatoshi Hashimoto, Naoki Yoshimura and Koji Kawai
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 543-551; DOI: https://doi.org/10.1124/jpet.114.214031

Z

  1. Zellars, Kia N.

    1. Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling
      Jeremy R. McGarvey, Sara Pettaway, James A. Shuman, Craig P. Novack, Kia N. Zellars, Parker D. Freels, Randall L. Echols, Jason A. Burdick, Joseph H. Gorman, Robert C. Gorman and Francis G. Spinale
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 701-709; DOI: https://doi.org/10.1124/jpet.114.215798

  2. Zhang, Minfang

    1. Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
      Weijia Xu, Xinghua Shao, Lei Tian, Leyi Gu, Minfang Zhang, Qin Wang, Bei Wu, Ling Wang, Jufang Yao, Xiaoping Xu, Shan Mou and Zhaohui Ni
      Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 552-562; DOI: https://doi.org/10.1124/jpet.114.214205
Back to top

In this issue